Skip to main content

Trafalgar International, Inc.

GCAND
Exchange
OTC
Industry
Pharmaceutical Preparations
SEC CIK
0001695473

No open-market purchases or sales by Trafalgar International, Inc. insiders were filed in the last 90 days; no institution reported holding it in 13F filings for Q2 2026; no superinvestor holds it.

Other share classesGCAN

Holders of 5% or more of GCAND

Holders whose latest Schedule 13D or 13G filing reports 5% or more of Trafalgar International, Inc., largest stake first. The change is against the holder's previous filing.

No holder currently reports owning 5% or more of Trafalgar International, Inc. on Schedule 13D or 13G.

Stakes are as of each holder's latest filing. Holders whose last filing was in the old format (before December 18, 2024) have no stake on record and are not listed, and after an acquisition or delisting holders usually stop filing.

13D and 13G filings

Schedule 13D and 13G filings on Trafalgar International, Inc., newest first.

No Schedule 13D or 13G filings on Trafalgar International, Inc. are on file.

Form 144: proposed insider sales

Notices from officers, directors and other affiliates planning to sell Trafalgar International, Inc. shares.

No Form 144 notices for Trafalgar International, Inc. are on file.